Abstract

Folylpoly-γ-glutamate synthetase (FPGS) catalyze the addition of multiple glutamates to tetrahydrofolate derivatives. Two mRNAs for the fpgs gene direct isoforms of FPGS to the cytosol and to mitochondria in mouse and human tissues. We sought to clarify the functions of these two compartmentalized isoforms. Stable cell lines were created that express cDNAs for the mitochondrial and cytosolic isoforms of human FPGS under control of a doxycycline-inducible promoter in the AUXB1 cell line. AUXB1 are devoid of endogenous FPGS activity due to a premature translational stop at codon 432 in the fpgs gene. Loss of folates was not measurable from these doxycycline-induced cells or from parental CHO cells over the course of three CHO cell generations. Likewise, there was no detectable transfer of folate polyglutamates either from the cytosol to mitochondria, or from mitochondria to the cytosol. The cell line expressing cytosolic FPGS required exogenous glycine but not thymidine or purine, whereas cells expressing the mitochondrial isoform required exogenous thymidine and purine but not glycine for optimal growth and survival. We concluded that mitochondrial FPGS is required because folate polyglutamates are not substrates for transport across the mitochondrial membrane in either direction and that polyglutamation not only traps folates in the cytosol, but also in the mitochondrial matrix.

Highlights

  • Folylpolyglutamates are in the cytosol and mitochondria and the enzyme that makes these compounds, folylpolyglutamate synthetase (FPGS) is in both compartments

  • Both cell lines appeared to be hemizygous at the FPGS locus, based on the fact that selection for revertants to prototrophy in either cell usually resulted in reversion of the parental Chinese hamster ovary (CHO) fpgs sequence

  • We directly examined the flux of folate polyglutamates across the mitochondrial membrane by incubating cells that had endogenous levels of FPGS only in the cytosol or in mitochondria using a modified pulse-chase experimental design with radiolabeled folate

Read more

Summary

Background

Folylpolyglutamates are in the cytosol and mitochondria and the enzyme that makes these compounds, folylpolyglutamate synthetase (FPGS) is in both compartments. To achieve the concentration of folate cofactors required for metabolism, mammalian cells use the enzyme folylpoly-␥-glutamate synthetase (FPGS) (EC 6.3.2.17) for the addition of several glutamate moieties successively linked to the ␥-carboxylate group on the glutamic acid intrinsic to all folates [6] The products of this reaction, the folylpoly-␥-glutamates, are thought to be poor substrates for efflux for the reduced folate carrier and proton-coupled folate transporter systems despite the fact that these transporters are clearly bidirectional [5, 7]. We present evidence that folate polyglutamates are not substrates for transport across the mitochondrial membrane in either direction nor can they efflux from intact cells at measurable rates over several cell generation times This impermeability of the mitochondrial and plasma membranes to the polyanionic folate polyglutamates explains the cellular requirement for subcellular isoforms of FPGS for optimal growth and survival

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call